• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Introduction to 3-(trifluoromethyl)-2,6-Pyridinediamine (CAS No. 1063697-16-4) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

3-(trifluoromethyl)-2,6-Pyridinediamine, identified by its Chemical Abstracts Service (CAS) number 1063697-16-4, is a heterocyclic organic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its unique structural features and versatile reactivity. The presence of a trifluoromethyl group at the 3-position of the pyridine ring, combined with the two amino substituents at the 2- and 6-positions, imparts distinct electronic and steric properties that make this compound a valuable scaffold for designing novel bioactive molecules.

The trifluoromethyl group is a well-documented pharmacophore that enhances metabolic stability, lipophilicity, and binding affinity in drug candidates. Its electron-withdrawing nature influences the electronic distribution of the pyridine ring, making it a suitable platform for further functionalization. The diamine moiety introduces basicity and potential for hydrogen bonding interactions, which are crucial for target recognition in biological systems. Together, these structural elements enable 3-(trifluoromethyl)-2,6-Pyridinediamine to serve as a versatile building block for the synthesis of small molecules with therapeutic potential.

In recent years, there has been growing interest in exploring the applications of 3-(trifluoromethyl)-2,6-Pyridinediamine in medicinal chemistry. Its pyridine core is a common motif in many bioactive compounds, including kinase inhibitors, antiviral agents, and anti-inflammatory drugs. The trifluoromethyl substituent has been particularly studied for its ability to modulate enzyme activity and improve pharmacokinetic profiles. For instance, derivatives of this compound have shown promise in inhibiting specific enzymes involved in cancer pathways by leveraging the steric and electronic effects of the trifluoromethyl group to enhance binding affinity.

One of the most compelling aspects of 3-(trifluoromethyl)-2,6-Pyridinediamine is its potential as a precursor for synthesizing more complex molecules with tailored biological activities. Researchers have utilized this scaffold to develop novel inhibitors targeting protein-protein interactions (PPIs), which are challenging to modulate with traditional small-molecule drugs. The amino groups at the 2- and 6-positions provide handles for further derivatization through amide bond formation, allowing chemists to introduce diverse functional groups that can fine-tune solubility, bioavailability, and target specificity.

Recent advances in computational chemistry have further enhanced the utility of 3-(trifluoromethyl)-2,6-Pyridinediamine by enabling high-throughput virtual screening and molecular docking studies. These computational approaches have facilitated the identification of novel derivatives with improved pharmacological properties. For example, virtual screening campaigns have highlighted several analogs of this compound that exhibit potent activity against kinases such as Janus kinases (JAKs) and tyrosine kinases (Tyrosine Kinase Inhibitors - TKIs). These findings underscore the importance of 3-(trifluoromethyl)-2,6-Pyridinediamine as a privileged scaffold in drug discovery efforts.

The biological activity of 3-(trifluoromethyl)-2,6-Pyridinediamine derivatives has been explored across various therapeutic areas. In oncology research, compounds derived from this scaffold have demonstrated preclinical efficacy against multiple cancer types by interfering with key signaling pathways involved in tumor growth and metastasis. The combination of the trifluoromethyl group's lipophilic properties with the amino groups' ability to form hydrogen bonds has been instrumental in designing molecules that can effectively penetrate cellular membranes and exert their effects inside cancer cells.

In addition to oncology, 3-(trifluoromethyl)-2,6-Pyridinediamine has shown promise in other disease areas. For instance, researchers have investigated its derivatives as potential treatments for inflammatory diseases by targeting inflammatory cytokines and signaling cascades. The unique electronic properties of the trifluoromethyl group have been exploited to enhance binding interactions with specific protein targets involved in immune responses. This has led to the development of novel anti-inflammatory agents that may offer improved efficacy compared to existing therapies.

The synthetic accessibility of 3-(trifluoromethyl)-2,6-Pyridinediamine also contributes to its appeal in medicinal chemistry research. Several synthetic routes have been reported for its preparation, including multi-step sequences involving condensation reactions between appropriately substituted pyridine precursors followed by functional group transformations. These synthetic strategies allow researchers to readily access large libraries of derivatives for structure-activity relationship (SAR) studies. The availability of high-quality starting materials ensures that chemists can efficiently explore new chemical space without encountering significant synthetic challenges.

Recent studies have also highlighted the role of 3-(trifluoromethyl)-2,6-Pyridinediamine in developing next-generation antibiotics. The structural motif has been incorporated into molecules designed to target bacterial enzymes essential for survival and replication. The presence of the trifluoromethyl group enhances metabolic stability against bacterial degradation enzymes while maintaining sufficient lipophilicity for effective membrane penetration. These findings suggest that compounds derived from this scaffold could address emerging antibiotic resistance challenges by targeting unique bacterial vulnerabilities.

The versatility of 3-(trifluoromethyl)-2,6-Pyridinediamine extends beyond pharmaceutical applications into agrochemical research. Derivatives of this compound have been explored as leads for developing novel herbicides and fungicides due to their ability to interact with essential enzymatic pathways in plants and fungi. The combination of electronic effects from the trifluoromethyl group and steric hindrance from the amino substituents allows these molecules to selectively inhibit target enzymes while minimizing toxicity to non-target organisms.

In conclusion,3-(trifluoromethyl)-2,6-Pyridinediamine (CAS No. 1063697-16-4) represents a promising scaffold with diverse applications across chemical biology and medicinal chemistry. Its unique structural features—particularly the presence of a trifluoromethyl group—make it an attractive building block for designing bioactive molecules with improved pharmacological properties. Ongoing research continues to uncover new therapeutic potentials for derivatives of this compound across various disease areas, underscoring its significance as a valuable resource in modern drug discovery efforts.

• 74784-70-6(5-(Trifluoromethyl)pyridin-2-amine)
• 183610-70-0(3-(trifluoromethyl)pyridin-2-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)